Efficacy of Moxifloxacin plus Treatment of Physician's Choice in Patients with Metastatic Breast Cancer.

CONCLUSION: The combination of moxifloxacin with previous TPC shows promising efficacy and well-tolerated toxicities in patients with MBC.
PMID: 32390277 [PubMed - as supplied by publisher]

Source: The Oncologist - May 10, 2020 Category: Cancer & Oncology Authors: Wang X, Shi W, Li J, Huang Z, Xia W, Huang J, Su Y, Wang S, Shi Y, Bi X, Yuan Z Tags: Oncologist Source Type: research